The Central Effects of a Nitric Oxide Synthase Inhibitor (Nω- Nitro - L - Arginine) on Blood Pressure and Plasma Renin
Authors:
- 1 January 1993
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 15 (5) , 819-832
Abstract
An endothelium-derived relaxing factor has been identified as nitric oxide (NO). Peripheral and central administration of nitric oxide synthase inhibitors result in an increase in renal sympathetic nerve activity and an increase in blood pressure. The goal of our study was to determine if the increase in blood pressure following central NO synthase inhibition with NM-nitro-L-arginine (L-NNA) is caused by the release of renin. Six groups of Sprague-Dawley rats were used. Group I (control) received intracerebroventricular (i.c.v.) artificial cerebrospinal fluid. Groups II & III received i.c.v. L-NNA, 5 & 15 μg/min. respectively. Group IV was treated with intravenous L-NNA, 15 μg/min. Group V, after bilateral nephrectomy, received i.c.v. L-NNA, 15 μg/min. Group VI received i.c.v. L-arginine, 60 μg/min. and i.c.v. L-NNA, 15 μg/min., simultaneously. Plasma renin concentration was measured in groups I, III, IV & V. Mean arterial blood pressure was significantly increased in groups II, III & V, i.e., following i.c.v. infusion of L-NNA. The increase in mean arterial blood pressure was significantly greater when the dose was increased from 5 to 15 μg/min. and it was eliminated when L-arginine was added to the infusion. The increase in blood pressure was attended by no change in heart rate. While the plasma renin concentration increased significantly in group III, this could not explain the increase in blood pressure since the nephrectomized group (V) showed no increase in renin concentration but an equivalent increase in blood pressure. The results show that acute central administration of a low dose of L-NNA increases blood pressure in rats and this increase can be prevented by central.Keywords
This publication has 22 references indexed in Scilit:
- L‐NITROARGININE INCREASES BLOOD PRESSURE IN THE RATClinical and Experimental Pharmacology and Physiology, 1991
- Glutamate, nitric oxide and cell-cell signalling in the nervous systemTrends in Neurosciences, 1991
- Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro ratsBritish Journal of Pharmacology, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Biosynthesis of nitric oxide from l-arginineBiochemical Pharmacology, 1989
- Role of endothelium-derived nitric oxide in the regulation of blood pressure.Proceedings of the National Academy of Sciences, 1989
- Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brainNature, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- The nature of endothelium-derived vascular relaxant factorNature, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980